-
公开(公告)号：KR1020130035323A
公开(公告)日：2013-04-09
申请号：KR1020110099525
申请日：2011-09-30
Applicant: (주)아모레퍼시픽
IPC: A61K36/82 , A61K31/7016 , A61K31/7028 , A61K31/56
CPC classification number: A61K31/704 , A61K8/602 , A61K8/97 , A61K36/82 , A61Q11/00 , Y10S514/8995
Abstract: PURPOSE: An oral composition containing saponin extracted from the root of Camellia sinensis is provided to ensure anticancer effect, to prevent or treat periodontal diseases, and to suppress or treat halitosis. CONSTITUTION: An oral composition contains 0.01-65 wt% of saponin extracted from the root of Camellia sinensis. The saponin is triterpenoid saponin. Triterpenoid saponin prevents and treats periodontal diseases and suppresses halitosis. [Reference numerals] (AA) Oral physiotherapy index; (BB) Baseline; (CC) After 2 months; (DD) After 5 months; (EE) Comparative example 1; (FF) Example 1; (GG) Example 2;
Abstract translation: 目的：提供从山茶根提取的含有皂苷的口服组合物，以确保抗癌作用，预防或治疗牙周病，抑制或治疗口臭。 构成：口服组合物含有0.01-65重量％的从山茶根提取的皂苷。 皂苷是三萜皂苷。 三萜皂苷预防和治疗牙周病，抑制口臭。 （附图标记）（AA）口服理疗指标; （BB）基线; （CC）2个月后; （DD）5个月后; （EE）比较例1; （FF）实施例1; （GG）实施例2;
-
112.发明公开필발 추출물, 이소플라본을 함유하는 대두 추출물 및 Ｌ-카르니틴을 함유하는 비만 또는 고지혈증 예방용 또는 개선용 조성물 有权用于预防或治疗肥胖或含有大剂量肝素提取物，异丙肾上腺素和左旋肉碱的组合物
公开(公告)号：KR1020120037145A
公开(公告)日：2012-04-19
申请号：KR1020100098725
申请日：2010-10-11
Applicant: (주)아모레퍼시픽
IPC: A61K36/67 , A61K31/352 , A61K31/35
Abstract: PURPOSE: A composition containisng Piper longum L. extract, isoflavone, and L-carnitine is provided to reduce body fat and body weight and to enhance energy consumption. CONSTITUTION: A composition for preventing or treating obesity contains 0.0001-10 wt% of Piper longum L. extract, 0.0001-10 wt% of isoflavone, and 0.001-40 wt% of L-carnitine as an active ingredient. The composition is used for suppressing neutral fat. A composition for treating or preventing hyperlipidemia contains the Piper longum L. extract, isoflavone, and L-carnitine as an active ingredient.
Abstract translation: 目的：提供琵琶龙提取物，异黄酮和L-肉碱的组合物，以减少体脂肪和体重，增加能量消耗。 构成：用于预防或治疗肥胖症的组合物含有0.0001-10重量％的琵琶龙提取物，0.0001-10重量％的异黄酮和0.001-40重量％的左旋肉碱作为活性成分。 该组合物用于抑制中性脂肪。 用于治疗或预防高脂血症的组合物含有琵琶长叶提取物，异黄酮和L-肉毒碱作为活性成分。
-
公开(公告)号：KR1020110110053A
公开(公告)日：2011-10-06
申请号：KR1020110029585
申请日：2011-03-31
Applicant: (주)아모레퍼시픽
IPC: A61K36/484 , A61K36/48 , A61P25/00 , A61P19/00
CPC classification number: A61K31/35 , A23L2/52 , A23L33/10 , A23L33/105 , A23L33/15 , A23P10/28 , A23P10/30 , A61K9/0095 , A61K31/37 , A61K36/48
Abstract: 본 발명은 쿠메스트롤 또는 쿠메스트롤을 포함하는 콩 추출물을 유효 성분으로 포함하는 미토콘드리아 활성화용 조성물을 개시한다.
-
公开(公告)号：KR1020110110052A
公开(公告)日：2011-10-06
申请号：KR1020110029582
申请日：2011-03-31
Applicant: (주)아모레퍼시픽
Abstract: 본 발명은 쿠메스트롤; 또는 쿠메스트롤을 포함하는 콩 추출물을 포함하는 피부 미용용 조성물을 개시한다.
-
公开(公告)号：KR1020110060002A
公开(公告)日：2011-06-08
申请号：KR1020090116467
申请日：2009-11-30
Applicant: (주)아모레퍼시픽
IPC: A61K36/82 , A61K31/715 , A61P1/16 , A61P25/32
Abstract: PURPOSE: A composition containing post-fermented tea extract an chitooligosaccharide is provided to reduce hangover and blood acetate concentration. CONSTITUTION: A composition for relieving hangover contains post-fermented tea extract and chitooligosaccharide in a weight ratio of 1:1-1:5. The post-fermented tea extract is obtained using non-pathogenic microorganism such as Saccharomyces sp., Bacillus sp., or Aspergillus sp. A liver protective agent or fatigue recovery agent contains the composition.
Abstract translation: 目的：提供含有发酵后茶提取物的壳寡糖的组合物，以减少宿醉和血液乙酸盐浓度。 构成：用于缓解宿醉的组合物含有重量比为1：1-1：5的后发酵茶提取物和壳低聚糖。 后发酵茶提取物是使用非致病微生物如酵母属，芽孢杆菌属或曲霉属种获得的。 肝保护剂或疲劳恢复剂含有该组合物。
-
Patent Agency Ranking
公开(公告)号：KR1020110058287A
公开(公告)日：2011-06-01
申请号：KR1020090115024
申请日：2009-11-26
Applicant: (주)아모레퍼시픽
IPC: A61K36/282 , A61P25/28 , A23L1/30 , A61K8/97
CPC classification number: A61K36/282 , A23L33/105 , A23V2002/00 , A23V2250/21 , A23V2200/316 , A23V2200/322
Abstract: PURPOSE: A composition containing Artemisia princeps or Artemisia iwayomogi extract is provided to promote PPAR-delta and to prevent and relieve dementia or Parkinson's disease. CONSTITUTION: A composition for improving muscle metabolism and memory contains 1-80 weight% of Artemisia princeps extract. The composition controls an enzyme expression which promotes intramuscular fat and glycosylation. The composition also prevents and relieves dementia or Parkinson's disease. A method for preparing the extract of Artemisia princeps or Artemisia iwayomogi comprises: a step of adding water or organic solvent to Artemisia princeps or Artemisia iwayomogi and stirring at 70-80 degrees Celsius for 3 hours twice; a step of filtering using Wahtman No.1 filter; and a step of freeze-drying to obtain solid powder. The organic solvent is ethanol, methanol, butanol, ether, ethyl acetate, and chloroform.
Abstract translation: 目的：提供含有青蒿或艾蒿提取物的组合物，以促进PPAR-δ和预防和缓解痴呆或帕金森病。 构成：用于改善肌肉代谢和记忆的组合物含有1-80重量％的艾蒿提取物。 该组合物控制促进肌内脂肪和糖基化的酶表达。 该组合物还可预防和缓解痴呆或帕金森病。 一种制备艾蒿提取物或青蒿提取物的方法包括：将水或有机溶剂加入到蒿蒿或艾蒿中，并在70-80摄氏度下搅拌3小时两次; 使用Wahtman 1号过滤器进行过滤; 和冷冻干燥步骤得到固体粉末。 有机溶剂为乙醇，甲醇，丁醇，乙醚，乙酸乙酯，氯仿。
-
117.发明公开리그난 유도체를 함유하는 세라마이드 대사관련 효소에 의해 매개되는 질환의 예방 또는 치료용 조성물 有权用于预防或治疗包含作为活性成分的Larianan衍生物的CERAMIDE代谢相关酶介导的疾病的组合物
公开(公告)号：KR1020100059050A
公开(公告)日：2010-06-04
申请号：KR1020080117688
申请日：2008-11-25
Applicant: (주)아모레퍼시픽
IPC: A61K31/192 , A61K31/343 , A61P3/00
CPC classification number: A61K31/192 , A61K31/343
Abstract: PURPOSE: A composition containing lignin derivative is provided to treat atopic dermatitis or xerosis to also treat diseases mediated by ceramide metabolic enzyme. CONSTITUTION: A composition for preventing or treating diseases mediated by ceramide metabolic enzyme contains rosmarinic acid of chemical formula 1, lithospermic acid of chemical formula 2, 9"-methyl lithospermate of chemical formula 2, or lignin derivative of 9'-methyl lithospermate of chemical formula 2 as an active ingredient. The composition enhances ceramide content on the epidermis.
Abstract translation: 目的：提供含有木质素衍生物的组合物治疗特应性皮炎或干性病，还可治疗由神经酰胺代谢酶介导的疾病。 构成：用于预防或治疗由神经酰胺代谢酶介导的疾病的组合物含有化学式1的迷迭香酸，化学式2的化学式2，化学式2的9“ - 甲基紫精的化学式，或化学式为9'-甲基紫苏的木质素衍生物 配方2作为活性成分。组合物增强表皮上的神经酰胺含量。
-
公开(公告)号：KR1020100032603A
公开(公告)日：2010-03-26
申请号：KR1020080091563
申请日：2008-09-18
Applicant: (주)아모레퍼시픽
IPC: G01N21/25 , G01N21/359 , G01N33/02
Abstract: PURPOSE: A method for verifying prediction about a yield and quality of a fresh red ginseng and red ginseng juice using a near-infrared-spectrum system is provided to verify a yield and quality in a short time through a correlation calibration curve. CONSTITUTION: A method for verifying prediction about a yield and quality of a fresh red ginseng and red ginseng juice using a near-infrared-spectrum system is as follows. Multiple fresh ginsengs are respectively measured using a near-infrared spectrum. The fresh ginsengs are processed to red ginsengs. Yields of the red ginsengs, red ginseng juice, ginsenoside contents, and moisture contents of the fresh ginsengs are measured. A correlation of a normal value and a spectrum is displayed as a calibration curve.
Abstract translation: 目的：提供一种使用近红外光谱系统验证新鲜红参和红参果汁的产量和质量的预测方法，通过相关校准曲线在短时间内验证产量和质量。 构成：使用近红外光谱系统验证新鲜红参和红参果汁的产量和质量的预测方法如下。 使用近红外光谱分别测量多个新鲜人参。 新鲜人参被加工成红参。 测定红参中红参，红参，人参皂甙含量，水分含量。 正常值和光谱的相关性显示为校准曲线。
-
公开(公告)号：KR100902223B1
公开(公告)日：2009-06-11
申请号：KR1020070074108
申请日：2007-07-24
IPC: A61K9/48
Abstract: 본 발명은 관절 및 연골의 구성성분으로 관절 및 연골의 건강에 도움을 주는 성분을 높은 밀도로 함유하는 연질 캡슐에 대한 것으로서, 캡슐의 안정성과 복용 후 붕해 속도를 개선하여 생체이용률을 향상시킨 연질 캡슐 제제에 관한 것이다. 더욱 구체적으로 본 발명은 글루코사민 또는 약제학적으로 허용되는 그 염을 한 유효 성분으로 하는 구성에 상어 연골 추출 분말, 생강 버드나무 추출 분말, 홉 추출물, 녹색입(green-lipped) 홍합 분말 중의 어느 하나 이상의 비글루코사민 유효 성분을 선택적으로 포함할 수 있는 연질 캡슐에 대한 것이다. 본 발명의 연질 캡슐은 붕해 안정성을 조절하기 위하여 호박산 젤라틴 및 중간 사슬 트리글리세리드유(MCT oil)를 사용하고, 인체에 안전한 천연 색소를 사용하였기 때문에 관절염 환자의 증상 완화와 관절 보호에 효과가 있을 것으로 예상된다.
글루코사민, 호박산 젤라틴, MCT, 연질 캡슐, 천연색소-
公开(公告)号：KR1020080049177A
公开(公告)日：2008-06-04
申请号：KR1020060119455
申请日：2006-11-30
Applicant: (주)아모레퍼시픽
CPC classification number: A61K8/72 , A61K8/19 , A61K8/22 , A61K8/55 , A61K8/736 , A61K8/81 , A61Q11/00
Abstract: An oral composition comprising a thermo-sensitive polymer is provided to be used conveniently as a sol phase before application to the oral cavity, deliver effective ingredients for a long time by being phase changed into a gel phase in the oral cavity and be removed easily by cleansing the oral cavity with cold water. An oral composition with a sol-gel phase transition formulation comprises 5-50 wt.% of a thermo-sensitive polymer, wherein the sol-gel phase transition temperature is 31-32 deg.C. The composition further comprises 0.001-10 wt.% of at least one foul breath removing ingredient selected from the group consisting of a pine needle extract, cetylpyridinium chloride, a green tea extract and a Salix koreensis extract. Further, the oral composition additionally comprises sodium pyrophosphate as an effective component.
Abstract translation: 提供了包含热敏性聚合物的口腔用组合物，其在施用于口腔之前方便地用作溶胶相，通过相变成口腔中的凝胶相长时间输送有效成分，并通过 用冷水清洗口腔。 具有溶胶 - 凝胶相变制剂的口服组合物包含5-50重量％的热敏聚合物，其中溶胶 - 凝胶相转变温度为31-32℃。 该组合物还包含0.001-10重量％的至少一种选自松针提取物，氯化十六烷基吡啶，绿茶提取物和柳枝稷提取物的去污成分组分的成分。 此外，口服组合物另外包含焦磷酸钠作为有效成分。
-
-
-
-
-
-
-
-
-
Search Results
183
records
(took 0.028 seconds)
